Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | SVP, Cont & Chief Acct Officer | June 26, 2026 | June 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date June 26, 2026 · Filed June 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (Restricted)SEC Table I · non-derivative | Direct | 27,606 |
Reported balance
After 2026-06-26 transaction · row 1
1 source rowRow 1 · 2026-06-26 · Tax withholding · Disposed 454 · Balance 27,606 F1: Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible. |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 30, 2020 Filed Apr 1, 2020 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 3,030 | $0.00 Strike: $54.53 | $0.00 |
DisclosureSEC source: 0001127602-20-012450 · form4.xml · derivative · entry 4 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,030 shares Expires 2020-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Remaining options became exercisable in four equal annual installments beginning on 4/1/2014. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 3,030 | $60.00 | $181,800.00 |
DisclosureSEC source: 0001127602-20-012450 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,760.2554 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 3,030 | $54.53 | $165,225.90 |
DisclosureSEC source: 0001127602-20-012450 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,790.2554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:38 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 1,912 | $59.18 | $113,152.16 |
DisclosureSEC source: 0001127602-20-009161 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,733 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan its Performance-Based Restricted Stock Unit Plan. Restrictions lapse in three equal installments, commencing February 28, 2021. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:38 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 347 | $59.18 | $20,535.46 |
DisclosureSEC source: 0001127602-20-009161 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,760.2554 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 24,240 | $54.19 Strike: $54.19 | $1,313,565.60 |
DisclosureSEC source: 0001127602-19-014682 · form4.xml · derivative · entry 3 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,240 Underlying: Common Stock · 24,240 shares Expires 2029-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2020. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 253 | $54.19 | $13,710.07 |
DisclosureSEC source: 0001127602-19-014682 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,135.2554 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under an incentive compensation plan. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 5,536 | $54.19 | $299,995.84 |
DisclosureSEC source: 0001127602-19-014682 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,793 F1 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2020. Read SEC document |
| March 01, 2019 Filed Mar 1, 2019 22:45 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 1,664 | $0.00 Strike: $45.07 | $0.00 |
DisclosureSEC source: 0001127602-19-009277 · form4.xml · derivative · entry 5 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,664 shares Expires 2019-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Remaining Options became exercisable in four equal annual installments beginning on 4/2/2013. Read SEC document |
| March 01, 2019 Filed Mar 1, 2019 22:45 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 1,664 | $45.07 | $74,996.48 |
DisclosureSEC source: 0001127602-19-009277 · form4.xml · nonDerivative · entry 4 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,557.2554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 1, 2019 22:45 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 1,664 | $58.14 | $96,744.96 |
DisclosureSEC source: 0001127602-19-009277 · form4.xml · nonDerivative · entry 3 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,893.2554 Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:45 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 1,323 | $57.83 | $76,509.09 |
DisclosureSEC source: 0001127602-19-009277 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,088 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan and its Performance-Based Restricted Stock Unit Plan. Restrictions lapse in three equal installments, commencing February 28, 2020. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:45 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 288 | $57.83 | $16,655.04 |
DisclosureSEC source: 0001127602-19-009277 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,557.2554 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of stock awards under the Issuer's 2017 Incentive Compensation Plan.. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.